Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project

INTRODUCTION: Amidst growing consensus that stakeholder decision-making during drug development should be informed by an understanding of patient preferences, the Innovative Medicines Initiative project ‘Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle’ (PREFER) is developi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Falahee, Marie, Simons, Gwenda, DiSantostefano, Rachael L, Valor Méndez, Larissa, Radawski, Christine, Englbrecht, Matthias, Schölin Bywall, Karin, Tcherny-Lessenot, Stephanie, Kihlbom, Ulrik, Hauber, Brett, Veldwijk, Jorien, Raza, Karim
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2021
Matèries:
Rheumatology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039213/
https://ncbi.nlm.nih.gov/pubmed/36916312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-045851
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars